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Randomized SMILES strings improve 
the quality of molecular generative models
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Abstract 
Recurrent Neural Networks (RNNs) trained with a set of molecules represented as unique (canonical) SMILES strings, 
have shown the capacity to create large chemical spaces of valid and meaningful structures. Herein we perform an 
extensive benchmark on models trained with subsets of GDB‑13 of different sizes (1 million, 10,000 and 1000), with 
different SMILES variants (canonical, randomized and DeepSMILES), with two different recurrent cell types (LSTM and 
GRU) and with different hyperparameter combinations. To guide the benchmarks new metrics were developed that 
define how well a model has generalized the training set. The generated chemical space is evaluated with respect 
to its uniformity, closedness and completeness. Results show that models that use LSTM cells trained with 1 million 
randomized SMILES, a non‑unique molecular string representation, are able to generalize to larger chemical spaces 
than the other approaches and they represent more accurately the target chemical space. Specifically, a model was 
trained with randomized SMILES that was able to generate almost all molecules from GDB‑13 with a quasi‑uniform 
probability. Models trained with smaller samples show an even bigger improvement when trained with randomized 
SMILES models. Additionally, models were trained on molecules obtained from ChEMBL and illustrate again that train‑
ing with randomized SMILES lead to models having a better representation of the drug‑like chemical space. Namely, 
the model trained with randomized SMILES was able to generate at least double the amount of unique molecules 
with the same distribution of properties comparing to one trained with canonical SMILES.
Keywords: Deep learning, Generative models, SMILES, Randomized SMILES, Recurrent Neural Networks, Chemical 
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Introduction
Exploring the unknown chemical space in a meaning-
ful way has always been one of the major objectives in 
drug discovery. Given the fact that the drug-like chemi-
cal space is enormous (the lower estimation is  1023 mol-
ecules) [1], it cannot be easily searched. One of the most 
interesting attempts to understand the chemical space is 
the GDB project [2], which encompasses a set of data-
bases that combinatorially enumerate large parts of the 
small molecule fragment-like chemical space. Currently 
there are databases that enumerate most fragment-like 
molecules with up to 13 (975 million molecules) [3] and 
17 (166 billion molecules) [4] heavy atoms. Another 
approach, GDB4c [5], enumerates ring systems up to four 
rings both in 2D (circa one million ring systems) and 3D 
(more than 6 million structures). Although managing 
billion-sized databases is computationally challenging, 
the enumerative approach has proven useful to study the 
entire small drug-like molecular chemical space in an 
unbiased way [6].
In the last 2  years molecular deep generative models 
have emerged as a powerful method to generate chemi-
cal space [7] and obtain optimized compounds [8]. Given 
a training set with molecules (generally a database such 
as ChEMBL [9]), these models learn how to create mol-
ecules that are similar but not the same as those in the 
training set, thus spanning a bigger chemical space than 
that of the training data. Either after or during training, 
the probability of generating molecules with specific 
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properties can be altered with techniques such as rein-
forcement [8] or transfer learning [7, 10]. Multiple archi-
tectures have been reported in literature: the first one is 
Recurrent Neural Networks (RNNs) [7], but also others 
such as Variational AutoEncoders (VAEs) [11], Genera-
tive Adversarial Networks (GANs) [12, 13], etc. [14]. Due 
to its simplicity, in most published research the format 
representing molecules is the canonical SMILES nota-
tion [15], a string representation unique to each mole-
cule. Nevertheless, models that use the molecular graph 
directly are starting to gain interest [16, 17].
Notwithstanding the popularity of RNNs, the idi-
osyncrasies of the canonical SMILES syntax can lead to 
training biased models [18]. Specifically, models trained 
with a set of one million molecules from GDB-13 have 
a higher probability of generating molecules with fewer 
rings. Additionally, the canonical SMILES representation 
can generate substantially different strings for molecules 
that are very similar, thus making some of them more dif-
ficult to sample. To prove this, these models were sam-
pled with replacement 2 billion times and at most only 
68% of GDB-13 could be obtained from a theoretical 
maximum of 87%. This maximum would be from sam-
pling with replacement the same number of times from 
a theoretical ideal model that has a uniform probability 
of obtaining each molecule from GDB-13, thus obtaining 
the least possible biased output domain.
We performed an extensive benchmark of RNN mod-
els trained with SMILES obtained from GDB-13 whilst 
exploring an array of architectural changes. First and 
foremost, models were trained with three different 
variants of the SMILES notation. One of them is the 
commonly used canonical SMILES, another one are ran-
domized SMILES (also known as enumerated SMILES), 
which have been used as a data amplification technique 
and are shown to generate more diversity in some model 
architectures [19–21]. The third one is DeepSMILES 
[22], a recently published modification of the canoni-
cal SMILES syntax. Secondly, models were trained with 
decreasing training set sizes (1,000,000, 10,000 and 
1000 molecules) to explore the data amplification capa-
bilities of randomizes SMILES. Thirdly, the two most 
used recurrent cell architectures were compared: long 
short-term memory (LSTM) [23] and Gated Recurrent 
Unit (GRU) [24]. GRU cells are widely used as a drop-
in replacement of LSTM cells with an noticeable speed 
improvement, but it has been shown that in some tasks 
they perform worse [25]. Fourthly, regularization tech-
niques such as dropout [26] in conjunction with different 
batch sizes were also tested and their impact on the gen-
erated chemical space assessed. All of the benchmarks 
were supported by a set of metrics that evaluate the uni-
formity, completeness and closedness of the generated 
chemical space. With this approach, the generated chem-
ical space is treated as a generalization of the training set 
to the entire GDB-13 and the chemical space exploration 
capability of the models can be assessed. Finally, to dem-
onstrate how the same methodology can be used to train 
models that generate real-world drug-like compounds, 
models were trained with a subset of the ChEMBL [9] 
database.
Methods
Randomized SMILES strings
To obtain canonical SMILES the atoms in a given mol-
ecule have to be uniquely and consistently numbered. In 
the case of RDKit this is done by using a modified ver-
sion of the Morgan algorithm [27, 28]. The SMILES 
generation algorithm is then able to traverse the molec-
ular graph always in the same way (Fig. 1a). Some atom 
CC(=O)Oc1ccccc1C(=O)O c1cc(c(cc1)C(O)=O)OC(C)=O c1cc(C(O)=O)c(OC(C)=O)cc1 
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Fig. 1 Traversal of the molecular graph of Aspirin using three methods: a the canonical ordering of the molecule; b atom order randomization 
without RDKit restrictions; c Atom order randomization with RDKit restrictions of the same atom ordering as b. Atom ordering is specified with a 
number ranking from 1 to 13 for each atom and the arrows show the molecular graph traversal process. Notice that the atom ordering is altered in 
c, prioritizing the sidechains (red arrows) when traversing a ring and preventing SMILES substrings like c1cc(c(cc1))
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orderings can lead to overly complicated SMILES strings 
and that is why RDKit has some built-in fixes that alter 
atom order on-the-fly. They prevent strange combina-
tions, such as prioritizing traversing sidechains before 
the ring atoms, and are by default active.
One easy way of obtaining randomized SMILES is by 
randomizing atom ordering. This does not alter how 
the algorithm traverses the graph (i.e., depth-first in the 
case of RDKit), but changes the starting point and in 
what order the branching paths are selected. With this 
approach, theoretically, at most n! different SMILES 
can be generated on a molecule with n heavy atoms, yet 
the resulting number of different combinations ends 
up being much lower. The two different variants of ran-
domized SMILES used here (Fig.  1b, c) only change on 
the application of the RDKit fixes. This makes the unre-
stricted version a superset of the restricted one, which 
includes the SMILES that are disallowed in the regular 
restricted version.
RNNs trained with SMILES
Pre‑processing SMILES strings
SMILES strings of all variants need to be tokenized to be 
understood by the model. Tokenization was performed 
on a character basis with the exception of some specific 
cases. The first are the “Cl” and “Br” atoms, which are 
two-character tokens. Second are atoms with explicit 
hydrogens or charge, which are between brackets (e.g., 
“[nH]” or “[O-]”). Third, ring tokens can be higher than 
9 in which case the SMILES syntax represents the num-
ber prepended with the “%” character (e.g., “%10”). These 
rules apply to all SMILES variants used in this research. 
Lastly, the begin token “^” was prepended and the end 
token “$” appended to all SMILES strings. The tokeniza-
tion process was performed independently for each data-
base and yielded vocabulary sizes of 26 in GDB-13 and 
31 in ChEMBL. When training the DeepSMILES models, 
the official implementation [22] was used to convert the 
SMILES.
Architecture
The model architecture used is similar to the one used 
in [7, 8, 18] and is illustrated in Fig.  2. The training set 
sequences are pre-processed, and for each training epoch 
the entire training set is shuffled and subdivided in b 
batches. The encoded SMILES strings of each batch are 
fed token by token to an embedding layer of m dimen-
sions, followed by l layers of LSTM [23] /GRU [24] cell 
size w . To prevent squeezing the encoded input, the 
embedding dimensions should be m ≤ w . Between the 
inner RNN layers there can be dropout layers [26] with 
a probability d . The output from the cells is squeezed to 
the vocabulary size v by a linear transformation layer and 
a softmax is performed to obtain the probabilities of sam-
pling each token in the next position. This is repeated for 
each token in the entire sequence.
Training a model
Following [18], all models have two sets: a training and 
a validation set. The validation set holds molecules 
that are in the target chemical space but are not used 
for training the model. Depending on the training set 
different splits can be made. In Table  1 is shown the 
size of the training and validation sets for each of the 
benchmarks (see Additional file 1: Methods S1 for more 
information on how the databases were filtered). In the 
case of models trained with randomized SMILES, a new 
sample of randomized SMILES of the same molecules 
are used for the training and validation set for each 
epoch. These training set files are created beforehand 
and the model uses a different file for each epoch. For 
example, a model trained with one million molecules 
RNN 
RNN 
Linear 
Embedding 
  
 
Dropout 
Dropout 
 
Somax 
… > 0 layers of size  
m  
dimensions 
| | 
Fig. 2 Architecture of the RNN model used in this study. For every 
step i  , input one‑hot encoded token Xi goes through an embedding 
layer of size m ≤ w , followed by l > 0 GRU/LSTM layers of size w with 
dropout in‑between and then a linear layer that has dimensionality w 
and the size of the vocabulary. Lastly a softmax is used to obtain the 
token probability distribution Yij . Hi symbolizes the input hidden state 
matrix at step i
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for 300 epochs will have approximately 300 million dif-
ferent randomized SMILES, although the number is 
generally lower because some SMILES are more com-
monly sampled than others.
During each epoch the training set is shuffled and 
minibatches of size b are created. These batches are 
in the form of a matrix with a row for each encoded 
SMILES string and appended with end tokens as pad-
ding. The “teacher’s forcing” approach is used in train-
ing, which means that the correct token is always input 
in the next step, regardless of the prediction from the 
model [29]. The loss function to minimize by the model 
is the average negative log-likelihood (NLL) of the 
entire batch of tokenized SMILES strings. Given Xi and 
xi as the sampled and expected token at previous step 
i ≥ 0 respectively and the current time step T ≥ 0 , the 
partial NLL of a SMILES string is computed as:
To prevent instability during training, the computed 
gradients are updated so that the norm is 1.0 . When 
performing a forward-pass on a batch, the model does 
not apply any mask to already finished sequences. This 
makes the model run slightly faster because no masks 
are computed and, as the padding token is the end of 
sequence, it does not affect the quality of the train-
ing process. All weight matrices are initialized from a 
uniform random distribution U
(−√1/w,√1/w) . The 
learning decay strategy is based on a custom metric 
calculated at each epoch (UC-JSD) and is discussed in 
section “Adaptive learning rate decay strategy” of the 
Additional file 1: Methods S2.
Benchmark
The models were optimized over the hyperparam-
eter combinations shown in Table  2. The two models 
with bigger training set sizes were optimized for fewer 
J (T ) = NLL(T ) = − ln P(X0 = xo)
−
T∑
t=1
ln P(Xt = xt |Xt−1 = xt−1 . . .X1 = x1)
parameters, as training times were much longer. On the 
other hand, the two smaller models allowed for more 
optimizations, as each epoch took few seconds to calcu-
late. After the first benchmark, GRU cells were dropped 
because of their consistently lower performance.
After each hyperparameter optimization, the best 
epoch was chosen as follows. A smoothing window func-
tion size 4 was applied to the UC-JSD calculated on each 
epoch, selecting the epoch with the lowest UC-JSD (see 
next section) as the best one.
UC‑JSD—a metric for generative models
The metric used for the benchmark is derived from pre-
vious research [18]. There, it was hypothesized that the 
best models are those in which the validation, train-
ing and sampled set NLL distributions are uniform and 
equivalent. The Jensen–Shannon Divergence (JSD) meas-
ures the divergence between a set of probability distribu-
tions [30] and is calculated as:
where H(d) is the Shannon entropy of a given probabil-
ity distribution and ∀d ∈ D; 0 < αd < 1 and 
∑
αd = 1 
are weights. The JSD→ 0 when ∀di ∈ D; di = dj; i �= j , 
which does not explicitly consider uniformity (i.e., the 
distributions can be non-uniform but equal).
To solve this issue the Uniformity–Completeness JSD (UC-
JSD) was designed. Instead of binning the raw distribution 
NLLs, each of the NLLs is used as it is. Given the three NLL 
vectors for the sampled, training and validation sets of the 
same size NLLS = {NLLvalidation,NLLtraining ,NLLsampled} 
and αi = 1/3 , the values in each vector are divided by the 
total sum, giving a probability distribution with as many val-
ues as items in the vector. Then (Eq. 1 is used to calculate the 
JSD between the three distributions. Notice that, since the 
model is sampled randomly, the UCJSD → 0 either in the 
highly unlikely case that all the samples have molecules with 
(1)JSD = H
(∑
d∈D
αi · di
)
−
∑
d∈D
αiH(di)
Table 1 Training and  validation set sizes for  the  different 
benchmarks
Notice that depending on the expected size of the target chemical space and 
the total amount of molecules, different ratios have been used
Model Training set size Validation set size
GDB‑13 1M 1,000,000 10,000
GDB‑13 10K 10,000 1000
GDB‑13 1K 1000 1000
ChEMBL 1,483,943 78,102
Table 2 Hyperparameter combinations used in  the  grid 
search
Number of layers (l), dimensions of the RNN layers (w), dropout rate % (d), batch 
size (b), RNN cell type (RNN)
Model l w d b RNN
GDB‑13 1M 3 512 0, 25, 50 64, 128, 256, 
512
GRU, LSTM
GDB‑13 10K 2, 3, 4 256, 384, 512 0, 25, 50 8, 16, 32 LSTM
GDB‑13 1K 2, 3, 4 128, 192, 256 0, 25, 50 4, 8, 16 LSTM
ChEMBL 3 512 0, 25, 50 64, 128, 256, 
512
LSTM
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the same NLL or all three distributions are uniform, and the 
model is complete.
Sampling the best epoch of a model
The main objective of sampling a model is to assess the 
properties of the output domain. Namely, in the case of 
GDB-13, the uniformity (equal probability of sampling), 
completeness (sampling all molecules from GDB-13) and 
closedness (only molecules from GDB-13 are sampled) are 
to be assessed. To ease the evaluation of the models, three 
ratios representing the three properties were defined.
Given a sample with replacement size k , the valid 
(SMILES parsed correctly with repeats), in (SMILES with 
repeats in GDB-13), unique (sampled unique canoni-
cal SMILES in GDB-13) subsets are obtained. Both 
ratiovalid = |valid|k  and ratioin =
|in|
k  are relative to the 
entire sample but ratiounique = |unique||GDB13| is relative to ϕ(k) , 
which represents the expected ratio of different molecules 
obtainable when a sample size k with replacement is per-
formed on a model that generates uniformly all mole-
cules from and only from GDB-13 (ideal model) [18] (i.e., 
ϕ
(
2 · 109) = 0.8712 ). This allows to define the ratios as:
Also, the UCC = completeness · uniformity · closedness 
was also defined as a unified score that heavily penalizes 
completeness = ratiounique
ϕ(k)
uniformity = ratiounique
ϕ(|in|)
closedness = ratioin
models that have low scores. See the Additional file  1: 
Methods S2–4 for further details on how the benchmark 
was performed.
Technical notes
All the software was coded in Python 3.6.8. The models 
were coded using the PyTorch 1.0.1 library [31]. Unless 
specified, the chemistry library used throughout is RDKit 
2019_03_01 [32] and for all the big data processing Spark 
2.4.3 [33] was used. All plots were made with matplot-
lib 3.0.3 [34] and seaborn 0.9.0 [35]. The GPU hardware 
used to train and sample the models were Nvidia Tesla 
V100 (Volta) 16  GB VRAM cards using CUDA 9.1 on 
stable driver 390.30. The MOSES and FCD benchmarks 
were calculated using the code provided in (https ://githu 
b.com/molec ulars ets/moses ).
Results
Optimizing generative models with 1 million SMILES 
from GDB‑13
Canonical vs. randomized SMILES
Hyperparameter optimizations of the three main SMILES 
variants (canonical, randomized restricted and rand-
omized unrestricted) were performed on models trained 
with 1 million molecules randomly sampled from GDB-
13 (Table  2). A k = 2 · 109 SMILES sample was per-
formed on the best epoch for each of the models trained 
in the benchmark (see Additional file  1: Methods S1). 
Results show (Table 3, Additional file 2: Figure S4 for the 
best hyperparameter combinations for each SMILES type 
and Additional file 3: Table S1 for all results) that the ran-
domized variants greatly outperform canonical SMILES. 
The best canonical SMILES model was only able to 
Table 3 Best models trained on subsets of GDB-13 after the hyperparameter optimization
See “Methods” section for a description of the ratios
Best result for each training set size are indicated in italics
Set Benchmark training set size, SMILES SMILES variant, including randomized variants with and without data augmentation (DA), Time training time up in hh:mm, 
% GDB-13 Percent of unique molecules from GDB‑13 generated in a 2 billion sample with replacement, Valid valid SMILES, Unif uniformity ratio, Comp completeness 
ratio, Closed closedness ratio, UCC UCC ratio
Set SMILES Time % GDB‑13 Valid Unif Comp Closed UCC 
1M Canonical 4:08 72.8 0.994 0.879 0.836 0.861 0.633
Rand. unr. 31:47 80.9 0.995 0.970 0.929 0.876 0.790
Rand. unr. no DA 1:37 77.0 0.987 0.957 0.795 0.883 0.672
Rand. rest. 7:19 83.0 0.999 0.977 0.953 0.925 0.860
Rand. rest. no DA 1:21 78.2 0.992 0.957 0.829 0.898 0.712
DS branch 1:33 72.1 0.987 0.881 0.828 0.834 0.608
DS rings 1:11 68.6 0.979 0.852 0.788 0.798 0.535
DS both 1:05 68.4 0.979 0.851 0.785 0.796 0.532
10K Canonical 0:04 38.8 0.905 0.666 0.445 0.426 0.126
Rand. rest. 0:36 62.3 0.974 0.882 0.715 0.598 0.377
1K Canonical 0:01 14.5 0.504 0.611 0.167 0.133 0.014
Rand. rest. 0:04 34.1 0.812 0.790 0.392 0.276 0.085
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enumerate 72.8% of GDB-13 compared to the 83.0% of 
the restricted randomized SMILES (Fig.  3). All three 
metrics, uniformity, completeness and closedness are 
much higher and show that the restricted randomized 
models are theoretically able to generate most of GDB-13 
with uniform probability. This can be further seen in 
Fig. 4b, where the NLL distribution of a sample of mole-
cules from the GDB-13 randomized SMILES models is 
centered at NLLGDB13 = −ln
(
1
|GDB13|
)
= 20.6 and is 
much narrower than that of the canonical variant model.
Comparing the two variants of randomized SMILES, 
models trained with both variants have a similarly uni-
form output domain (Fig. 4b), but models trained with 
restricted randomized variant have a more complete 
and more closed domain than those trained with the 
unrestricted variant. The output domain of the ideal 
randomized SMILES models would comprise all pos-
sible SMILES strings of any given variant possible to 
be generated from all molecules in GDB-13. This con-
trasts with the canonical model, in which the output 
domain is one SMILES per molecule. Each molecule 
has a different number of SMILES strings, depending 
on its topology, although only a few (generally highly 
cyclic or branched molecules) have numbers above 
1000 (Fig.  4a). Knowing that the training objective is 
to obtain a uniform posterior distribution, it would 
be expected that molecules with more randomized 
SMILES should have a higher probability of being sam-
pled than those that have fewer. However, this is never 
the case as models trained with randomized SMILES 
have a much more uniform posterior probability dis-
tribution than those trained with canonical SMILES 
(Fig. 4b). The model naturally learns to prioritize some 
SMILES in molecules with a large number of possi-
ble SMILES, and to have a more uniform distribution 
among all possible SMILES on molecules that have less. 
This can be seen in Fig. 4c, where two molecules have 
the same NLL, but one (blue) has six times the number 
of possible SMILES than the other (orange).
Models trained with randomized SMILES without data 
augmentation (the same SMILES strings each epoch) 
were also benchmarked. Results show (Table  3, Addi-
tional file 2: Figure S4 for the best hyperparameter com-
binations for each SMILES type and Additional file  3: 
Table S1 for all results) that they perform better than the 
models trained with canonical SMILES but worse than 
those with data augmentation. This indicates that not 
using the canonical representation constraint makes bet-
ter models, but also that data augmentation has a positive 
impact on the training process.
DeepSMILES is a SMILES syntax variant that alters the 
syntax and changes how rings and branching are repre-
sented [22]. Three different forms of DeepSMILES were 
explored: one with the new ring syntax, another with the 
Fig. 3 Plot illustrating the percent of GDB‑13 sampled alongside the sample size of the ideal model (blue) and the best of the canonical (yellow), 
randomized restricted (green) and randomized unrestricted (orange) models. Notice that the ideal model is always an upper bound and eventually 
( n ∼ 21B ) would sample the entire GDB‑13. The trained models would reach the same point much later
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new branching syntax and a last one with both changes. 
Results show (Table  3, Additional file  3: Table  S1 com-
plete) that the performance is consistently lower than 
using normal canonical SMILES. The validity is generally 
1–3% lower than in canonical SMILES, possibly indicat-
ing that the model has difficulties in learning the basics 
of the syntax.
The hyperparameter optimization also gives some 
hints on how dropout, batch size and cell type affect 
the training process, although it varies for each SMILES 
variant. Plots for each hyperparameter compared to the 
four ratios and the training time were drawn (Addi-
tional file  2: Figure S1) and show that adding drop-
out only makes canonical SMILES models better. The 
model improves its completeness, but at the expense of 
closedness, meaning that it generates more molecules 
from GDB-13 at the expense of making more mistakes. 
On the other hand, larger batch sizes have generally a 
positive impact in models of all SMILES variants and 
at the same time make training processes much faster. 
But the most interesting result is that the best models 
for all SMILES variants use LSTM cells. Moreover, even 
though the training time per epoch of the GRU cells 
is lower, LSTM models are able to converge in fewer 
epochs.
Similarity maps for the randomized SMILES were also 
plotted (Additional file  2: Figure S2) and confirm that 
models trained with randomized SMILES are able to 
generate mostly all molecules from GDB-13 with uni-
form probability. Only molecules on the left tip of the 
half-moon (highly cyclic) are slightly more difficult to 
generate, but this is because they have extremely compli-
cated SMILES with uncommon tokens and ring closures. 
Additionally, maps colored by the number of SMILES 
per molecule were created and show that most of the 
molecules that have more randomized SMILES are the 
same as those that are difficult to sample in the canonical 
models.
Fig. 4 Histograms of different statistics from the randomized SMILES models. a Kernel Density Estimates (KDEs) of the number of randomized 
SMILES per molecule from a sample of 1 million molecules from GDB‑13. The plot has the x axis cut at 5000, but the unrestricted randomized 
variant plot has outliers until 15,000. b KDEs of the molecule negative log‑likelihood (NLL) for each molecule (summing the probabilities for each 
randomized SMILES) for the same sample of 1 million molecules from GDB‑13. The plot is also cropped between range (19, 25) . c Histograms 
between the NLL of all the restricted randomized SMILES of two molecules from GDB‑13
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UC‑JSD can be used to predict the best models
The previous benchmark employed an adaptive learning 
rate strategy (see Additional file 1: Methods S2) that uses 
the UC-JSD metric to evaluate the quality of the models 
and trigger a learning rate change. Moreover, the same 
metric was used to select the best epochs to perform a 
sample for each model. Plotting the UC-JSD against UCC 
shows a strong correlation in all three SMILES variants 
(Fig. 5). It is important to notice that the UC-JSD values 
should not be compared between models, as the out-
put domain is different. This result shows that it is not 
necessary anymore to sample all models, but only the 
one that has the best UC-JSD. That is why for all future 
benchmarks only the model with the lowest UC-JSD 
is sampled. Moreover, the GRU cells have not shown 
any improvement whatsoever compared to the LSTM 
cells (Additional file  2: Figure S1) and the unrestricted 
randomized SMILES variant performs worse than the 
restricted variant. Henceforth, only the restricted variant 
of randomized SMILES and LSTM cells will be used for 
the next benchmarks.
Training generative models with smaller training sets
To further show the data augmentation capabilities of 
randomized SMILES, two models were trained with 1000 
and 10,000 molecules respectively, randomly obtained 
from GDB-13. Hyperparameter optimization was modi-
fied to accommodate smaller training sets and, as mod-
els were faster to train, different network topologies were 
tested (Table  2). When the training sets are so small, 
models are often unable to learn the syntax properly and 
thus generate more invalid structures. The model using 
1000 molecules was the most affected by this problem, 
with some models not even reaching 50% validity. This 
impacts the accuracy of the UC-JSD, because all mol-
ecules tend to have a sampling probability p→ 0 . This 
makes the UC-JSD have low values because all molecules 
have very similar probability. For this reason, only models 
that had more than 50% valid SMILES were considered.
Results show (Table 3, Additional file 3: Table S1 com-
plete) that models trained with randomized SMILES 
have better performance than those trained with canoni-
cal SMILES. In the models trained with 1000 molecules, 
those with canonical SMILES are at most able to gener-
ate up to 70% valid SMILES, although the best model 
was only able to generate 50% valid SMILES. Moreover, 
the completeness ratio of the best model is only 0.1325, 
meaning that most of the SMILES generated are not part 
of GDB-13: they correspond to molecules containing fea-
tures excluded from GDB-13 (e.g. strained rings, unstable 
functional groups, wrong tautomer). Alternatively, the 
models trained with randomized SMILES show a much 
better behavior. Most models learn how to generate 
SMILES strings correctly (validity over 80%), complete-
ness is much higher (0.2757) and their posterior distri-
bution is more uniform. This is further illustrated with 
the fact that randomized SMILES models generate up to 
34.11% of unique GDB-13 molecules and canonical mod-
els only 14.54%.
Models trained with a bigger sample of 10,000 mol-
ecules show similar trends but have much better perfor-
mance in both cases. In this case, a model trained with 
randomized SMILES is able to uniquely generate 62.29% 
of GDB-13 while only training with less than 0.001% of 
the database, whereas a canonical SMILES model is only 
able to generate 38.77%. Closedness is much better in 
Fig. 5 Linear regression plots between the UC‑JSD and the UCC ratio. a Canonical SMILES R2 = 0.931 . b Restricted randomized SMILES R2 = 0.856 . 
c Unrestricted randomized SMILES R2 = 0.885
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both models: canonical SMILES models have at most 
0.4262, whereas randomized SMILES models up to 
0.5978. Lastly, a large number of SMILES generated are 
not included in GDB-13, meaning that the model, even 
though generating valid molecules, does not fully learn 
the specific idiosyncrasies of GDB-13 molecules and gen-
erates valid molecules that break some condition.
Improving the existing ChEMBL priors with randomized 
SMILES
The same benchmark study was also performed on mod-
els with a drug-like training set from ChEMBL (see Addi-
tional file  1: Methods S1 for more information on how 
the training set was obtained). A different and reduced 
set of hyperparameter values were used due to long train-
ing times (Table 2). The best models for both the canoni-
cal and restricted randomized SMILES benchmarks 
were obtained using the same procedure as before and a 
2 billion sample was performed. Results show (Table  4, 
extended results Additional file 3: Table S2) that the out-
put domain of the canonical model is much smaller than 
that of the randomized SMILES model. Specifically, the 
randomized SMILES model can generate at least twice 
the number of different molecules than the canonical. 
Nevertheless, the Fréchet ChemNet Distance (FCD) [36] 
between the validation set and a sampled set of 75,000 
SMILES is lower on the canonical SMILES model. This 
could mean that the molecules generated by the canoni-
cal model have more similar properties than ChEMBL 
molecules, but it could also mean that the canonical 
model overfits and generates molecules that are similar 
to the training set given that the validation set and the 
training set are biased the same way (i.e., they are both 
obtained from a biased sample of the entire drug-like 
chemical space).
To prove that the molecules sampled from the ran-
domized SMILES model are at least as diverse as those 
in the canonical, several physicochemical properties and 
metrics (as used in the MOSES benchmark [37]), such 
as molecular weight, logP, Synthetic Accessibility Score 
(SA) [38], Quantitative Estimate of Drug-likeness Score 
(QED) [39], Natural-Product likeness score (NP) [40] and 
Internal Diversity (cross-molecule Tanimoto similarity 
on ECFP4) were calculated for a sample of the training, 
validation, randomized SMILES model and canonical 
SMILES model (Additional file  2: Figure S3). All of the 
plots are nearly identical, showing that there is no clear 
difference between molecules in any of the four sets. 
Additionally, molecule NLL plots for the same four sam-
ples were calculated for both models (Fig.  6) and show 
that the canonical model greatly overfits the training and 
validation sets compared to the randomized SMILES 
model, which has mostly the same distribution for both 
sets. When comparing the two samples, the canonical 
model has much lower probabilities of generating most 
of the molecules generated by the randomized SMILES 
model, but not the opposite. The randomized SMILES 
model is able to generate the canonical SMILES model 
Table 4 Best models from  the  ChEMBL benchmark 
for both SMILES variants
SMILES SMILES variant, Time time used to train the model hhh:mm, % Valid 
Percent of valid molecules, % Unique Percent of unique molecules in a 2 billion 
SMILES sample, Fréchet ChemNet Distance (FCD) between the validation and a 
sample of 75,000 molecules (FCD)
SMILES Time % Valid % Unique FCD
Canonical 131:32 98.26 34.67 0.0712
Rest. Random. 84:22 98.33 64.09 0.1265
Fig. 6 Kernel Density Estimates (KDEs) of the Molecule negative log‑likelihoods (NLLs) of the ChEMBL models for the canonical SMILES variant (left) 
and the randomized SMILES variant (right). Each line symbolizes a different subset of 50,000 molecules from: Training set (green), validation set 
(orange), randomized SMILES model (blue) and canonical SMILES model (yellow). Notice that the Molecule NLLs for the randomized SMILES model 
(right) are obtained from the sum of all the probabilities of the randomized SMILES for each of the 50,000 molecules (adding up to 320 million 
randomized SMILES), whereas those from the canonical model are the canonical SMILES of the 50,000 molecules
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molecules with higher likelihood than average, implying 
that the output domain of the canonical SMILES model 
is a subset of the randomized SMILES model output 
domain.
Discussion
Why are randomized SMILES better?
A SMILES molecular generative model learns by finding 
patterns in the SMILES strings from the training set with 
the goal of generalizing a model that is able to obtain all 
the SMILES in the training set with the highest possible 
probability. The procedure is exactly the same with any 
SMILES variant, the only thing that changes is the string 
representation of each molecule and, in the case of rand-
omized SMILES, the number of different representations 
each molecule has. When the canonical representation is 
used, the model learns to generate one linear representa-
tion of each molecule obtained through a canonicaliza-
tion algorithm. This means that the model must learn not 
only to generate valid SMILES strings, but also to gener-
ate those in the canonical form. As shown in “Methods” 
section (Fig. 1), the canonicalization algorithm in RDKit 
does not only traverse the molecule using a fixed order-
ing, but also adds some restrictions on how to traverse 
rings. Moreover, models tend to see the same patterns 
repeatedly, leading to premature overfitting (Fig.  6). 
Alternatively, randomized SMILES models do not have 
the canonical form limitation and can learn the SMILES 
syntax without restriction. When no data augmentation 
is used, randomized SMILES still perform substantially 
better than canonical SMILES. Additionally, heavy regu-
larization with dropout in canonical models gave a better 
overall performance, but opposite results were obtained 
with randomized SMILES, showing that using different 
randomized SMILES on each epoch also serves as a regu-
larization technique.
Another way of understanding why randomized vari-
ants are better is to draw a parallel with image classifi-
cation models. For example, when an image classification 
model is trained to predict whether an image depicts a 
cat, the model performance can be improved with a 
training set that has examples of cats from all the pos-
sible angles and not always a front picture. This is not 
always easy to obtain in image predictive models, but in 
the case of molecular generative models it is extremely 
easy to generate snapshots of the same molecule from dif-
ferent angles (i.e., different ways of writing the SMILES 
string). This allows models to better learn the constraints 
of the training set chemical space (i.e., in the case of 
GDB-13: heteroatom ratios, allowed functional groups, 
etc.). Nevertheless, for each molecule there is a differ-
ent number of randomized SMILES (Fig.  4), thus pos-
sibly generating a bias towards the molecules that have 
more representations. None was detected in this study 
possibly because larger and highly branched molecules, 
which tend to have more combinations, are also generally 
more difficult to sample and can, in effect, counteract the 
bias (Fig. 4c). Lastly, the restricted variant of randomized 
SMILES performed best, indicating that restricting the 
randomized SMILES algorithm makes the model gener-
alize better. For example, the unrestricted randomized 
SMILES can represent the phenyl ring of aspirin (Fig. 1) 
in a much more convoluted way “c1cc(c(cc1)”, some-
thing that would be impossible in the restricted variant. 
Finding variants that perform even better should be a 
future research goal in this field.
Understanding diversity in molecular generative models
A challenge in Computer-Assisted Drug Design (CADD) 
is to computationally generate or evaluate molecules that 
fit a given set of constraints. This process is not devoid 
of error: for instance, an inactive molecule can be pre-
dicted as active (false positive) or an active one can be 
predicted as inactive (false negative). From a drug design 
perspective, false positives are more damaging due to 
the economic impact a wrong prediction can have. False 
negatives do not impact as directly but are important 
nonetheless: the next blockbuster could be any molecule 
wrongly skipped by computational solutions.
Analogously, the same problem can be brought to 
generative models. A model can generate molecules 
that are outside of the target chemical space (false posi-
tives) or the output domain can collapse [41] not being 
able to generate a chunk of the expected chemical space 
(false negatives). This is very easy to assess when training 
models that generate the GDB-13 chemical space. First, 
any molecule sampled not included in GDB-13 is a false 
positive (closedness). It was previously shown [18] that 
the vast majority of these clearly do not comply to one 
or more conditions of GDB-13, such as having invalid 
functional groups, molecular graph or not being the most 
stable tautomer. Alternatively, any molecule comprised 
in GDB-13 not possible to being sampled (i.e. very high 
NLL) becomes a false negative (completeness). In both 
cases this means that the model is not able to learn cor-
rectly the rules used in the enumeration process. When 
canonical and randomized SMILES models are com-
pared, the results show that randomized SMILES models 
perform substantially better in both properties (Table 3). 
They are able to learn better the filters used in enumerat-
ing GDB-13 and thus prevent the generation of incorrect 
molecules and at the same time generate more difficult 
outliers that comply with GDB-13 (Additional file 2: Fig-
ure S1, left tip of the NLL similarity maps).
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Training molecules on unknown target chemical spaces 
is a much more difficult task. Compared to GDB-13, 
where the generated molecules can be checked whether 
or not they form part of it, there is no way of bound-
ing the limits (if there are any) of a drug-like space. This 
makes benchmarking models much more complex. For 
instance, a model could generate an extremely diverse set 
of molecules, most of which are completely unrelated to 
the training set chemical space, compared to a model that 
generates less diverse and fewer molecules that are more 
akin to the training set chemical space. As it is unknown 
which is the target chemical space, assessing which is the 
best model is impossible. For this reason, some methods 
were published [37, 42] that aggregate a set of metrics 
to obtain a better overview of the output domain of the 
model. Unfortunately, they compare the models with a 
test set split from the training set and this tends to ben-
efit models that overfit. Additionally, they are not able to 
measure mode collapse the same way as with the GDB-13 
benchmark, as can be seen in [43]. This means that mod-
els may seem extremely diverse when being sampled a 
few thousand times, but when being sampled more times 
the same molecules start appearing repeatedly. This is 
the case with the ChEMBL models trained here. We 
know that the drug-like chemical space is huge [44], so 
we would not expect the model to collapse early. Results 
show that those trained with randomized SMILES have 
a much larger output domain (at least double) than 
those trained with canonical SMILES. Moreover, sets 
of molecules generated are physicochemically almost 
indistinguishable (Additional file 2: Figure S3) from sets 
generated from the canonical SMILES model, meaning 
that they are from the same chemical space. This show-
cases how models trained with randomized SMILES are 
able to represent chemical spaces that are more complete 
and at least as closed as those generated by models using 
canonical SMILES.
SMILES generative models as action‑based generative 
models
The most common way of understanding SMILES gen-
erative models is as grammar-based models that gener-
ate SMILES strings that are similar to the training set 
[7, 8], akin to language generative models [45]. Alterna-
tively, SMILES generative models can be also understood 
as action (or policy)-based graph generative models [16, 
46] in which a molecular graph is built stepwise. In these 
models, each step an action is chosen (“add atom”, “add 
bond”, etc.) and is sampled from a fixed or varying size 
action space (or policy) that has all possible actions (even 
invalid ones) alongside the probability of each happen-
ing. A parallelism can be partially drawn for SMILES 
generative models: the vocabulary is the action space in 
which atom tokens (“C”, “N”, “[O-]”, etc.) are “add atom” 
actions, the bond tokens (“=”, “#”, etc.) are “add bond” 
actions as are also the ring and branching tokens. The 
main difference is that “add atom” actions are always 
adding the new atom to the last atom added, the bond 
tokens add a bond to an unknown atom, which is speci-
fied just after, and the ring and branching tokens add also 
bonds and enable the model to jump from one place to 
another. Moreover, a single bond is by default added if no 
bond is specified between atoms when at least one is ali-
phatic, and an aromatic bond is added otherwise.
One of the main issues with graph generative models 
is that the action space can grow dangerously large, mak-
ing it very challenging to train models that generate big 
molecules [46]. This is not the case of SMILES generative 
models, as they only have to choose every epoch among 
a limited number of options (i.e., the vocabulary). On 
the other hand, SMILES models traverse the graph in a 
very specific way, they do not allow as many options as 
graph models. This is specially the case with canonical 
SMILES: Morgan numbering greatly reduces the possi-
ble paths, as it tends to prioritize starting in sidechains 
rather than in the rings of the molecule [28]. This makes 
sense when grammatically simpler SMILES strings are 
desired. We think that when using randomized SMILES, 
models become more action-based rather than grammar-
based. Additionally, this may also indicate why the syntax 
changes added in DeepSMILES have a detrimental effect 
on the learning capability of SMILES generative mod-
els, as they give the model a more complex action space. 
For instance, the ring token altered behavior makes the 
ring closures extremely grammar sensitive and the new 
branching token behavior makes the SMILES strings 
unnecessarily longer without any appreciable improve-
ment. We think that the SMILES syntax is, with all its 
peculiarities, an excellent hybrid between action-based 
and grammar-based generative models and is, to our 
knowledge, the most successful molecular descriptor for 
deep learning based molecular generation available so far.
Conclusions
In this research we have performed an extensive bench-
mark of SMILES-based generative models with a wide 
range of hyperparameters and with different variants 
of the SMILES syntax. To guide the benchmark a new 
metric, the UC-JSD, based on the NLL of the training, 
validation and sampled sets was designed. Our study 
shows that training LSTM cell-based RNN models using 
randomized SMILES substantially improves the qual-
ity of the generated chemical space without having to 
change anything in the generative model architecture. 
In the case of models trained with a sample of 1 million 
GDB-13 molecules, the best models are able to generate 
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almost all molecules from the database with uniform 
probability and generating very few molecules outside 
of it. Using smaller training set sizes (10,000 and 1000) 
further highlights the data augmentation effect of ran-
domized SMILES and enables training models that are 
able to generate 62% of GDB-13 with only a sample com-
prising 0.001% of the database. When training models 
on a ChEMBL training set, randomized SMILES models 
have a much bigger output domain of molecules in the 
same range of physicochemical properties as the canoni-
cal SMILES models. Moreover, randomized SMILES 
models can easily generate all molecules of the canonical 
SMILES output domain. The randomized SMILES vari-
ant that gave the best results is the one that has restric-
tions, compared to the one that is able to generate all 
possible randomized SMILES for each molecule. Regard-
ing different RNN hyperparameters and architectures, 
we wholeheartedly recommend using LSTM cells instead 
of GRU, due to their improved learning capability. Never-
theless, dropout and batch size have varying behavior on 
each training set, thus we would recommend perform-
ing a hyperparameter optimization to obtain the best 
values. We envision that randomized SMILES will play 
a significant role in generative models in the future and 
we encourage researchers to use them in different model 
architectures and problems, such as classification and 
prediction models.
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